https://stock.noler.com/us/stock/point-biopharma-global-inc https://stock.noler.com/us/stock/point-biopharma-global-inc/accounts-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/accounts-payable-other-current https://stock.noler.com/us/stock/point-biopharma-global-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/point-biopharma-global-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/accrued-liabilities-current https://stock.noler.com/us/stock/point-biopharma-global-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/point-biopharma-global-inc/accumulated-depreciation https://stock.noler.com/us/stock/point-biopharma-global-inc/additional-paid-in-capital https://stock.noler.com/us/stock/point-biopharma-global-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/point-biopharma-global-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/aoci https://stock.noler.com/us/stock/point-biopharma-global-inc/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/assets-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/point-biopharma-global-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/point-biopharma-global-inc/basic-shares https://stock.noler.com/us/stock/point-biopharma-global-inc/capital-expenditures https://stock.noler.com/us/stock/point-biopharma-global-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/point-biopharma-global-inc/cash https://stock.noler.com/us/stock/point-biopharma-global-inc/cash-and-equivalents https://stock.noler.com/us/stock/point-biopharma-global-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/point-biopharma-global-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/point-biopharma-global-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/point-biopharma-global-inc/cash-flow-breakdown https://stock.noler.com/us/stock/point-biopharma-global-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/point-biopharma-global-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/point-biopharma-global-inc/commercial-paper-at-carrying-value https://stock.noler.com/us/stock/point-biopharma-global-inc/common-dividends-paid https://stock.noler.com/us/stock/point-biopharma-global-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/point-biopharma-global-inc/common-stock-value https://stock.noler.com/us/stock/point-biopharma-global-inc/comprehensive-income https://stock.noler.com/us/stock/point-biopharma-global-inc/contract-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/point-biopharma-global-inc/current-assets https://stock.noler.com/us/stock/point-biopharma-global-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/current-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/debt-face-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/point-biopharma-global-inc/debt-redemption-price-percentage-of-principal-amount-redeemed https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-costs https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/point-biopharma-global-inc/deferred-tax-liabilities-unrealized-currency-transaction-gains https://stock.noler.com/us/stock/point-biopharma-global-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/point-biopharma-global-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/point-biopharma-global-inc/depreciation https://stock.noler.com/us/stock/point-biopharma-global-inc/diluted-shares https://stock.noler.com/us/stock/point-biopharma-global-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/point-biopharma-global-inc/due-to-related-parties-current https://stock.noler.com/us/stock/point-biopharma-global-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/point-biopharma-global-inc/eps https://stock.noler.com/us/stock/point-biopharma-global-inc/eps-basic https://stock.noler.com/us/stock/point-biopharma-global-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-current https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-right-of-use-asset-before-accumulated-amortization https://stock.noler.com/us/stock/point-biopharma-global-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/point-biopharma-global-inc/financing-cash-flow https://stock.noler.com/us/stock/point-biopharma-global-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/foreign-pretax-income https://stock.noler.com/us/stock/point-biopharma-global-inc/general-and-administrative-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/income-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/income-taxes-paid https://stock.noler.com/us/stock/point-biopharma-global-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/point-biopharma-global-inc/income-taxes-receivable https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/point-biopharma-global-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/point-biopharma-global-inc/insider-transactions-other https://stock.noler.com/us/stock/point-biopharma-global-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/point-biopharma-global-inc/interest-bearing-deposits-in-banks https://stock.noler.com/us/stock/point-biopharma-global-inc/interest-costs-capitalized https://stock.noler.com/us/stock/point-biopharma-global-inc/interest-income-expense-net https://stock.noler.com/us/stock/point-biopharma-global-inc/interest-paid-net https://stock.noler.com/us/stock/point-biopharma-global-inc/investing-cash-flow https://stock.noler.com/us/stock/point-biopharma-global-inc/investment-income-interest https://stock.noler.com/us/stock/point-biopharma-global-inc/lease-cost https://stock.noler.com/us/stock/point-biopharma-global-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/point-biopharma-global-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/point-biopharma-global-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/point-biopharma-global-inc/long-term-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/long-term-notes-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/point-biopharma-global-inc/net-change-in-cash https://stock.noler.com/us/stock/point-biopharma-global-inc/net-income https://stock.noler.com/us/stock/point-biopharma-global-inc/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/notes-payable-current https://stock.noler.com/us/stock/point-biopharma-global-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/point-biopharma-global-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/oci-net-of-tax https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-cash-flow https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-expenses https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-income https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-assets https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-cost https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-liability-current https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments-due https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/point-biopharma-global-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/point-biopharma-global-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/point-biopharma-global-inc/other-current-assets https://stock.noler.com/us/stock/point-biopharma-global-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/other-underwriting-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/point-biopharma-global-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/point-biopharma-global-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/point-biopharma-global-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/point-biopharma-global-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/point-biopharma-global-inc/payments-to-acquire-other-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/preferred-shares-facts https://stock.noler.com/us/stock/point-biopharma-global-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/point-biopharma-global-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/point-biopharma-global-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/point-biopharma-global-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/point-biopharma-global-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/point-biopharma-global-inc/prepaid-expense-current https://stock.noler.com/us/stock/point-biopharma-global-inc/prepaid-insurance https://stock.noler.com/us/stock/point-biopharma-global-inc/pretax-income https://stock.noler.com/us/stock/point-biopharma-global-inc/pretax-income-domestic https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/point-biopharma-global-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/point-biopharma-global-inc/profit-loss https://stock.noler.com/us/stock/point-biopharma-global-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/point-biopharma-global-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-after-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/point-biopharma-global-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-before-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/point-biopharma-global-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/point-biopharma-global-inc/property-plant-equipment https://stock.noler.com/us/stock/point-biopharma-global-inc/public-float https://stock.noler.com/us/stock/point-biopharma-global-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/point-biopharma-global-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/point-biopharma-global-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/point-biopharma-global-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/point-biopharma-global-inc/research-and-development https://stock.noler.com/us/stock/point-biopharma-global-inc/retained-earnings https://stock.noler.com/us/stock/point-biopharma-global-inc/revenue https://stock.noler.com/us/stock/point-biopharma-global-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/point-biopharma-global-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/point-biopharma-global-inc/share-price https://stock.noler.com/us/stock/point-biopharma-global-inc/shareholders-equity https://stock.noler.com/us/stock/point-biopharma-global-inc/shares-authorized https://stock.noler.com/us/stock/point-biopharma-global-inc/shares-issued https://stock.noler.com/us/stock/point-biopharma-global-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/point-biopharma-global-inc/short-term-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-based-compensation https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/point-biopharma-global-inc/stock-split-ratio https://stock.noler.com/us/stock/point-biopharma-global-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/point-biopharma-global-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/point-biopharma-global-inc/taxes-payable-current https://stock.noler.com/us/stock/point-biopharma-global-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/point-biopharma-global-inc/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/point-biopharma-global-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/point-biopharma-global-inc/total-assets https://stock.noler.com/us/stock/point-biopharma-global-inc/total-contract-liability https://stock.noler.com/us/stock/point-biopharma-global-inc/total-liabilities https://stock.noler.com/us/stock/point-biopharma-global-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/point-biopharma-global-inc/transfer-of-investments https://stock.noler.com/us/stock/point-biopharma-global-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/point-biopharma-global-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/point-biopharma-global-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/point-biopharma-global-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/point-biopharma-global-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/point-biopharma-global-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/point-biopharma-global-inc/weighted-average-number-of-share-outstanding-basic-and-diluted